RSD, autoimmune disorders and the questions worth asking
Reflex sympathetic dystrophy (RSD) is an older name still used by some patients for what clinicians usually call complex regional pain syndrome (CRPS). CRPS is a regional pain disorder that may follow injury, surgery or illness. It affects the nervous system, immune signalling and affected limbs.
The relationship between RSD and autoimmune disorders is complex and not yet settled. Evidence points to abnormal inflammation, immune-cell activity and possible autoantibody involvement, while no single laboratory test can confirm either condition. Symptoms can overlap, yet their causes, medicines and rehabilitation needs are not interchangeable.
RSD, CRPS and immune dysregulation
Current thinking treats CRPS as a clinical syndrome with several biological contributors rather than a disease caused by one faulty antibody. Sensory changes, abnormal blood-flow regulation, inflammation and altered autonomic control can all contribute. Psychological factors such as fear of movement may amplify disability, but they do not make physical symptoms imaginary.
Researchers have reported shared inflammatory pathways with rheumatoid arthritis and other immune conditions. An existing autoimmune disease may increase biological susceptibility, yet CRPS can develop without diagnosed autoimmunity. These findings support cautious investigation, not the claim that every case is autoimmune or that an autoimmune treatment will suit every patient.
When autoimmune disorders overlap with CRPS
Some people with CRPS also have rheumatoid arthritis, lupus, inflammatory bowel disease or another autoimmune condition. A flare of the original disease may cause joint pain, fatigue and swelling resembling CRPS, particularly in the same region. Treating the underlying illness remains essential and should be coordinated with pain specialists.
CRPS itself can produce inflammation, tenderness and autonomic changes without a separate autoimmune diagnosis. The overlap may reflect shared genes, cytokines, complement proteins or immune-cell pathways. Because laboratory markers are not decisive, clinicians compare symptoms, examine the area and exclude other causes before attributing changes to CRPS.
Symptoms that deserve attention
Pain is often the most obvious feature, but disproportionate sensitivity, allodynia, swelling, colour or temperature differences, sweating changes and stiffness can matter just as much. An overview of hair and nail changes explains why visible changes should be documented rather than dismissed, especially when they occur alongside limb pain.
Symptoms may vary and need not progress in a fixed order. Heat, cold, weather changes, long commutes and desk work can trigger a flare for some people, while others notice little pattern. Tracking triggers, sleep, medication and movement in a short diary can give a GP or rehabilitation team useful information.
Why diagnosis is not a blood test
The Budapest clinical criteria are commonly used to support diagnosis. They assess disproportionate pain, sensory changes, autonomic or vasomotor signs, swelling and motor or trophic changes. Diagnosis still depends on the whole clinical picture; an examination by an experienced professional is more informative than any single sign.
Blood tests may check for autoimmune or inflammatory conditions, and imaging can exclude arthritis, fractures, infection or structural problems. Nerve blocks can help treatment but cannot alone prove CRPS. Sudden red swelling, fever, chest pain or breathlessness needs urgent assessment rather than being assumed to be CRPS.
Treatment and rehabilitation in practice
No single treatment reliably cures CRPS, so care is usually multidisciplinary and begun early. A plan may combine pain medicine, physiotherapy, occupational therapy, sleep support and psychological care. Persistent pain can affect confidence, mood, work and relationships, making psychological support part of whole-person care. Treatment is tailored to the person, and temporary pain does not automatically mean permanent harm.
Graded movement and desensitisation are central to rehabilitation. Physiotherapy might use gentle contact, mirror work, coordination drills and progressively restored daily activities. People are encouraged to avoid both forced painful exercise and prolonged immobilisation. Reliable sources of specialist pain information can support questions and discussions between appointments.
Medicines may include analgesics, neuropathic-pain medicines, anti-inflammatory treatment or short-term corticosteroids in selected cases under specialist guidance. Other options, including nerve blocks and some infusion-based treatments, require individual assessment. Evidence is strongest for combined care, with access, contraindications and personal goals shaping decisions.
Navigating health care in Australia
In Australia, most people begin with a GP, who can refer them to a pain clinic, rheumatologist, neurologist, rehabilitation specialist or public hospital service. In Sydney, Melbourne and Brisbane, public and private pain services sit alongside community rehabilitation, while telehealth can widen access in rural and remote areas. Hands-on assessment may still be needed.
Australian pharmacies supply over-the-counter products, and many listed prescription medicines are subsidised through the Pharmaceutical Benefits Scheme. The Therapeutic Goods Administration regulates medicines sold here, so checking labels and discussing supplements is important when immune disease or organ function complicate treatment.
Workplace support can involve a return-to-work plan, practitioner reports and state workers' compensation schemes such as icare in New South Wales or WorkCover in Western Australia. Eligibility and insurer processes differ. The NDIS may support disability-related needs for eligible people, but it is not a treatment program. When illness also leads to exploitation or workplace discrimination, Brooks-County's victim contact page provides another avenue for finding relevant support.
A practical plan for people affected by RSD
A useful plan should describe what is happening, what remains uncertain and which goals matter most. It should record medication, activity, sleep, symptoms and changes between appointments, without assuming every new sensation represents worsening tissue damage.
Shared decisions work best when the person understands benefits, side effects and alternatives. These steps offer a structure for discussion with a GP and allied-health team:
- Ask for a written care plan naming the treating professionals, review dates and emergency contacts.
- Request tests or imaging only when the clinical assessment gives a reason to exclude another condition.
- Record pain, swelling, sleep, activity and possible triggers without repeatedly testing painful movements.
- Set one functional goal for each rehabilitation block, such as walking a familiar distance or preparing a meal.
- Tell the care team about autoimmune diagnoses, medicines, supplements, falls and changes in mood or sleep.
- Review progress every four to six weeks, or sooner after a significant flare, and adjust the plan rather than escalating everything at once.
Persistent regional pain, sensitivity or visible limb changes deserve assessment, especially after an injury, operation or illness. A GP can help establish whether CRPS, an autoimmune flare, nerve injury or another condition best fits the pattern, and can coordinate a referral.
General information cannot replace an individual assessment, so speak with your GP or treating team about symptoms, treatment choices and rehabilitation goals, and take a concise symptom record to the appointment.